Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission

Clinical and Experimental Immunology

Volumn 131, Issue 3, 2003, Pages 528-535

  Ohlsson, Sophie ^a,c   Wieslander, J ^b   Segelmark, M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Wieslab AB   (Sweden)

^c Kidney Research Laboratory   (Sweden)

Author keywords

ANCA; Autoimmunity; Neutrophil; Proteinase 3; Systemic vasculitis

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN C; INTERLEUKIN 6; LIPOCALIN; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRANULATION; DISEASE ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SMALL VESSEL VASCULITIS; SYSTEMIC VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIGENS; AUTOIMMUNITY; CELL DEGRANULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; MALE; MIDDLE AGED; MONOCYTES; MYELOBLASTIN; NEUTROPHIL ACTIVATION; SERINE ENDOPEPTIDASES; VASCULITIS;

EID: 0345700717     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02083.x     Document Type: Article

References (31)

1. Segelmark M, Westman K, Wieslander J. How and why should we detect ANCA? Clin Exp Rheumatol 2000; 18:629-35.
2. van der Geld YM, Limburg PC, Kallenberg CG. Proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol 2001; 69:177-90.
3. Campbell EJ, Campbell MA, Owen CA. Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition. J Immunol 2000; 165:3366-74.
4. Yang JJ, Tuttle RH, Hogan SL et al. Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol 2000; 121:165-72.
5. Esnault VL. ANCA-positive vasculitis and alpha 1-antitrypsin deficiency: could free ANCA antigens released by neutrophils mediate vasculitic lesions? Nephrol Dial Transplant 1997; 12:249-51.
6. Esnault VL, Audrain MA, Sesboue R. Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis. Exp Clin Immunogenet 1997; 14:206-13.
7. Segelmark M, Elzouki AN, Wieslaner J, Eriksson S. The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995; 48:844-50.
8. Gencik M, Meller S, Borgmann S, Fricke H. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 2000; 58:2473-7.
9. Bank U, Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol 2001; 69:197-206.
10. Borregaard N, Cowlaand JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89:3503-21.
11. Logdberg L, Wester L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta 2000; 1482:284-97.
12. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human neutrophii lipocalin. Scand J Clin Lab Invest 1995; 55:577-88.
13. Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 2000; 1482:298-307.
14. Aggerwal BB, Kohr WJ, Hass PE et al. Human tumor necrosis factor. Production, purification and characterization. J Biol Chem 1985; 260:2345.
15. Diez-Ruiz A, Tilz GP, Zangerle R et al. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54:1.
16. Barton BE. Molecule of the month. IL-6: insights into novel biological activities. Clin Immunol Immunopathol 1997; 85:16-20.
17. Baslund B, Petersen J, Permin H et al. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. J Immunol Meth 1994; 17:215-25.
18. Henshaw TJ, Malone CC, Gabay JE, Williams RC Jr. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1994; 37:104-12.
19. Sommarin Y, Rasmussen N, Wieslander J. Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies. Exp Nephrol 1995; 3:249-56.
20. Sköld S, Rosberg B, Gullberg U, Olofsson T. A secreted proform of neutrophil proteinase 3 regulates the proliferation of granulopoietic progenitor cells. Blood 1999; 93:849-56.
21. Sköld S, Zeberg L, Gullberg U, Olofsson T. Functional dissociation between proforms and mature forms of proteinase 3, azurocidin and granzyme B in regulation of granulopoiesis. Exp Hematol 2002; 30:689-96.
22. Ohlsson K, Linder C, Lundberg E, Axelsson L. Release of cytokines and proteases from human peripheral blood mononuclear and polymorphonuclear cells following phagocytosis and LPS stimulation. Scand J Clin Lab Invest 1996; 56:461-70.
23. Westman K, Selga D, Segelmark M et al. Clinical evaluation of a capture-ELISA for PR3-ANCA. Kidney Int 1998; 53:1230-6.
24. Wiik A, Rasmussen N, Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. In: van Venrooij W.J., Maini R.N., eds. Manual of biological markers of disease. Kluwer Academic Publishers, 1993; A9:1-14.
25. Haubitz M, Schulzeck P, Schellong S et al. Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 1997; 40:1680-4.
26. Bergenfeldt M, Berling R, Ohlsson K. Levels of leukocyte proteases in plasma and peritoneal exudate in severe, acute pancreatitis. Scand J Gastroenterol 1994; 29:371-5.
27. Perlmutter DHGG, Rivetna M, Schasteen CS. Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc Natl Acad Sci USA 1990; 87:3753-7.
28. Muller Kobold AC, Kallenberg CG, Tervaert JW. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Br J Rheumatol 1998; 37:901-7.
29. Taekema-Roelvink ME, Van Kooten C, Heemskerk E et al. Proteinase 3 interacts with a 111-kD membrane molecule of human umbilical vein endothelial cells. J Am Soc Nephrol 2000; 11:640-8.
30. Taekema-Roelvink ME, Van Kooten C, Kooij SV et al. Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol 2001; 12:932-40.
31. Yang JJ, Preston GA, Pendergraft WF et al. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 2001; 158:581-92.